Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 6.880
- +0.540+8.52%
Close Dec 20 16:00 ET
- 6.540
- -0.340-4.94%
Post 20:01 ET
324.84MMarket Cap-4.10P/E (TTM)
7.090High6.160Low984.13KVolume6.280Open6.340Pre Close6.71MTurnover3.84%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High2.75P/B176.25MFloat Cap5.81052wk Low--Dividend TTM25.62MShs Float35.000Historical High--Div YieldTTM14.67%Amplitude4.545Historical Low6.815Avg Price1Lot Size
Silence Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 2, 2024
The average Silence Therapeutics stock price target is 61.50 with a max estimate of 75.00 and a min estimate of 49.00
Review Silence Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 2, 2024